PI11330 2',2'-Difluoro-2'-deoxycytidine-3',5'-dibenzoate (CAS No.: 134790-39-9)

2',2'-Difluoro-2'-deoxycytidine-3',5'-dibenzoate (CAS No.: 134790-39-9) Description

2',2'-Difluoro-2'-deoxycytidine-3',5'-dibenzoate is a nucleoside derivative employed as an intermediate in the synthesis of complex pharmaceutical molecules. Its defined molecular formula, C23H19F2N3O6, ensures predictable chemical behaviour during reaction processes. The powder form facilitates accurate weighing and handling, supporting reproducible dosing in laboratory-scale and manufacturing settings.

2',2'-Difluoro-2'-deoxycytidine-3',5'-dibenzoate (CAS No.: 134790-39-9) Applications

Pharmaceutical Synthesis
   - Used as an intermediate in the production of nucleoside analogues to achieve efficient reaction pathways by leveraging its specific reactivity.
   - Applied as a key component in multi-step synthesis processes to control reaction kinetics and product consistency.

Chemical Research and Development
   - Serves as a model compound in structure-activity relationship studies to optimise synthesis routes by utilising its well-characterised molecular structure.
   - Frequently used for method development in reaction optimisation, enhancing experimental reproducibility and yield.

2',2'-Difluoro-2'-deoxycytidine-3',5'-dibenzoate (CAS No.: 134790-39-9) Packing

The compound is packaged in moisture-resistant, airtight containers to minimise exposure to ambient humidity. Each package incorporates anti-static materials and protective inserts to mitigate the risk of contamination and mechanical damage. Storage instructions recommend a cool, dry environment. Custom packaging options, including labelled secondary containers, are available to meet specific laboratory or industrial requirements.

Additional Information

The development of nucleoside intermediates like 2',2'-Difluoro-2'-deoxycytidine-3',5'-dibenzoate plays a significant role in pharmaceutical synthesis. Its chemical structure allows for predictable reactivity and fine-tuning of synthesis parameters in the production of antiviral and other therapeutic agents. Understanding these materials enhances process efficiency and supports continuous improvement in drug development methodologies.

Advanced control over synthesis parameters and material handling further supports innovations in pharmaceutical research. Detailed insights into molecular behaviour contribute to the reliable scaling of laboratory procedures to industrial manufacturing, ensuring that product characteristics remain consistent during production.